RESEARCH TRIANGLE PARK, NC – October 14, 2014 – Quintiles today announced that the company was awarded the Society for Clinical Research Sites’ (SCRS) 2014 Clinical Research Organization (CRO) Eagle Award. The award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication, was presented during the annual SCRS Site Solutions Summit.
"It is such an honor to be recognized again and receive this award for the second year in a row,” said Lindy Jones, senior vice president, Integrated Site Services, Quintiles. “Our ambition of transforming clinical development and accelerating pipelines to achieve better patient outcomes is only possible through the dedication and hard work of our investigators and sites. I would like to thank the investigators who voted for us. We will continue to look at how we can better partner together.”
“We are delighted to present the Eagle Award to Quintiles,” said SCRS President Christine Pierre. The award reflects the opinions of almost 2,000 investigative sites across the globe. Quintiles’ integrity in consistently demonstrating their keen interest in partnering with sites landed them with this prestigious recognition.”
Prior to the Site Solutions Summit, SCRS members, which are investigative sites, were invited to nominate the sponsor and CRO they believe best demonstrates partnership commitment. The other criteria include: availability of qualified staff to support the sites, demonstration of collaboration, protocol design and execution, financial consideration, and partnering with sites for future work. The finalists were those sponsors and CROs that ranked in the 75th percentile or greater of nominations received. Once the finalists were identified, voting was open to all sites globally.
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 29,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
SCRS is a trade organization representing global clinical research sites representing sites in 39 countries. SCRS’ mission is to unify the voice of the global clinical research site community for site sustainability. SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives. Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will benefit from membership. Visit www.myscrs.org
Mari Mansfield, Media Relations (email@example.com)
+ 1.919.998.2639 (office) +1.919.259.3298 (mobile)
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)